QuorumCivic. Hidden in plain sight Get the app
Bill intelligence
Full Simple

Federal AI push to accelerate pediatric cancer diagnosis and treatment

H.R. 10370 — Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act · Filed by Michael McCaul (R-TX) · 2 cosponsors · Introduced Sep 14, 2026 · Referred to committee

85%
Transparency
Typical bill: 85%
8/100
Hidden-provision risk
Typical bill: 15/100
Pediatric Cancer Research Coordination

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill directs the federal government to coordinate efforts using artificial intelligence and advanced technologies to improve diagnosis, treatment, and prevention of pediatric cancer. It establishes a coordinator position in the executive branch, expands the Childhood Cancer Data Initiative to collect and share patient data across agencies, and requires development of interoperability standards so AI tools can work with electronic health records and research data while protecting patient privacy.

Why we flagged it

The bill's core mechanism is establishing federal coordination and data infrastructure for AI-driven pediatric cancer research. It is a public-health research initiative, not a regulatory change, appropriation rider, or private carve-out.

What the text implies

  • Interoperability standards developed for pediatric cancer (Section 203) are explicitly designed for application throughout HHS, not limited to CCDI—may create broader precedent for AI-integrated health data exchange across federal health programs.
  • CCDI Director position requires 'demonstrated scientific expertise' but is designated by the Secretary on NCI Director recommendation—creates a new senior scientific leadership role within NIH structure with potential long-term institutional impact.
  • Data standardization and AI readiness activities (Section 202) are disseminated to 'the public' as appropriate—may accelerate private-sector AI tool development for pediatric oncology without explicit IP protections or benefit-sharing mechanisms.
  • Bill authorizes $100M annually for CCDI (2027–2031) but leaves other coordination and AI activities under open-ended 'such sums as may be necessary' language—actual total federal spend is undefined.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens—particularly families with children facing cancer—gain access to improved diagnostic tools, treatment options, and research acceleration through coordinated federal AI deployment and expanded data sharing. The bill includes privacy protections and patient engagement mechanisms, and creates no new restrictions on citizens' rights or remedies.

Who stands to gain

  • pediatric cancer research institutions
  • health information technology vendors (EHR/interoperability platforms)
  • AI software developers in healthcare
  • academic medical centers and cancer research centers

Named in the bill

National Institutes of Health (NIH), National Cancer Institute (NCI), Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), Advanced Research Projects Agency for Health (ARPA-H), Office of the National Coordinator for Health Information Technology, Department of Defense, Department of Energy, Department of Veterans Affairs, National Science Foundation, National Institute of Standards and Technology, Office of Science and Technology Policy — and 3 more

Where it stands

2 cosponsors: 1 Democrats, 1 Republicans.

  • Sep 14, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Sep 14, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Sep 2026 to Sep 2026. Those filings disclosed $120,000 in lobbying spend. A filing names 56 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Michael McCaul, the sponsor, reported $80,800 in PAC receipts in the 2026 cycle.

  • Blood Cancer United (fka the Leukemia & Lymphoma Society) — $120,000 on 1 filing

Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (12,512 characters) on Sep 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Sep 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.

“Federal AI push to accelerate pediatric cancer diagnosis and treatment” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10370 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.